Current issues in immunomodulatory treatment of multiple sclerosis - A practical approach

被引：6
|
作者：
Stangel, M
Gold, R
Gass, A
Haas, J
Jung, S
Elias, W
Zettl, UK
机构：
[1] Hannover Med Sch, Dept Neurol, D-30625 Hannover, Germany
[2] Univ Gottingen, Inst MS Res, D-3400 Gottingen, Germany
[3] Univ Basel, Dept Neurol, CH-4003 Basel, Switzerland
[4] Univ Saarland, Dept Neurol, Homburg, Germany
[5] Univ Rostock, Dept Neurol, D-2500 Rostock 1, Germany
来源：
JOURNAL OF NEUROLOGY | 2006年 / 253卷 / Suppl 1期
关键词：
D O I：
10.1007/s00415-006-1108-9
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：32 / 36
页数：5
相关论文
共 50 条
  • [41] Current treatment options in multiple sclerosis
    Boissy A.
    Fox R.J.
    Current Treatment Options in Neurology, 2007, 9 (3) : 176 - 186
  • [42] Multiple sclerosis: current treatment algorithms
    Rio, Jordi
    Comabella, Manuel
    Montalban, Xavier
    CURRENT OPINION IN NEUROLOGY, 2011, 24 (03) : 230 - 237
  • [43] A Bayesian approach to the analysis of immunomodulatory treatments effect on multiple sclerosis course
    Bergamaschi, R
    Quaglini, S
    Berzuini, C
    Tonietti, S
    Candeloro, E
    Romani, A
    Persico, A
    Cosi, V
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S159 - S160
  • [44] Urgent Issues in Multiple Sclerosis A Practical Guide for Non-Neurologists
    Udawatta, Methma
    Matiello, Marcelo
    MEDICAL CLINICS OF NORTH AMERICA, 2025, 109 (02) : 401 - 423
  • [45] Clinical characteristics of multiple sclerosis patients undergoing immunomodulatory treatment in Poland
    Kulakowska, A.
    Wawrzyniak, S.
    Koziarska, D.
    Adamczyk-Sowa, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E309 - E310
  • [46] Turning Mechanistic Immunomodulatory insights into personalized treatment strategies for multiple sclerosis
    Ntranos, Achilles
    Sand, Ilana Katz
    Casaccia, Patrizia
    NEUROLOGY, 2019, 92 (15)
  • [47] Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of Multiple Sclerosis
    Gharibi, Tohid
    Ahmadi, Majid
    Seyfizadeh, Narges
    Jadidi-Niaragh, Farhad
    Yousefi, Mehdi
    CELLULAR IMMUNOLOGY, 2015, 293 (02) : 113 - 121
  • [48] The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis
    Warrender-Sparkes, Matthew
    Spelman, Tim
    Izquierdo, Guillermo
    Trojano, Maria
    Lugaresi, Alessandra
    Grand'Maison, Francois
    Havrdova, Eva
    Horakova, Dana
    Boz, Cavit
    Oreja-Guevara, Celia
    Alroughani, Raed
    Iuliano, Gerardo
    Duquette, Pierre
    Girard, Marc
    Terzi, Murat
    Hupperts, Raymond
    Grammond, Pierre
    Petersen, Thor
    Fernandez-Bolanos, Ricardo
    Fiol, Marcela
    Pucci, Eugenio
    Lechner-Scott, Jeannette
    Verheul, Freek
    Cristiano, Edgardo
    Van Pesch, Vincent
    Petkovska-Boskova, Tatjana
    Moore, Fraser
    Kister, Ilya
    Bergamaschi, Roberto
    Laura Saladino, Maria
    Slee, Mark
    Barnett, Michael
    Amato, Maria Pia
    Shaw, Cameron
    Shuey, Neil
    Young, Carolyn
    Gray, Orla
    Kappos, Ludwig
    Butzkueven, Helmut
    Kalincik, Tomas
    Jokubaitis, Vilija
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (04) : 520 - 532
  • [49] Comparison of immunomodulatory therapies in treatment of relapsing-remitting multiple sclerosis
    Aydin Canturk, I.
    Isik, N.
    Unsal, A.
    Arici, O.
    Yildiz, N.
    Candan, F.
    MULTIPLE SCLEROSIS, 2006, 12 : S96 - S96
  • [50] Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis
    Varrin-Doyer, Michel
    Zamvil, Scott S.
    Schulze-Topphoff, Ulf
    EXPERIMENTAL NEUROLOGY, 2014, 262 : 66 - 71
12345